Zhuo Xi
Shenyang, 110004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Retraction notice to "MiR-383 inhibits proliferation, migration and angiogenesis of glioma-exposed endothelial cells in vitro via VEGF-mediated FAK and Src signaling pathways" [Cellular Signaling 30 (2017) 142-153].
Journal: Cellular signalling
Published: August 12, 2026
Corrigendum to "Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152" [Cancer Lett. 2015 Apr 1;359(1):75-86].
Journal: Cancer letters
Published: March 03, 2026
Recent update on the discovery of indoleamine-2,3-dioxygenase 1 inhibitors targeting cancer immunotherapy.
Journal: European journal of medicinal chemistry
Published: June 17, 2025
Dancing with KAT6A: Current advances and therapeutic potential in oncology of KAT6A inhibitors.
Journal: Bioorganic chemistry
Published: May 19, 2025
Differences in the rate of distal junctional problems between L3 and L4 pedicle subtraction osteotomy.
Journal: Journal of neurosurgery. Spine
Published: April 14, 2025
USPs and non-coding RNAs: Unraveling their interplay within tumor microenvironment for targeted cancer therapy.
Journal: Pharmacological research
Published: March 23, 2025
SIRT1: a novel regulator in colorectal cancer.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 26, 2024
Drug resistance mechanisms and treatment strategies mediated by Ubiquitin-Specific Proteases (USPs) in cancers: new directions and therapeutic options.
Journal: Molecular cancer
Published: February 03, 2024
Integrated Analysis of Multiomics Data Identified Molecular Subtypes and Oxidative Stress-Related Prognostic Biomarkers in Glioblastoma Multiforme.
Journal: Oxidative medicine and cellular longevity
Published: July 07, 2022
Retraction Notice to: Role of HCP5-miR-139-RUNX1 Feedback Loop in Regulating Malignant Behavior of Glioma Cells.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 07, 2022
Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme.
Journal: BioMed research international
Published: June 02, 2021
Last Updated: 09/26/2026